anti-white matter antibodies that mainly recognized astrocytes. Intravenous steroid followed by oral steroid reduced the symptoms to a remarkable degree. The patient has now been successfully sustained with steroid for more than two years. Weconsidered that this case is classified as non-paraneoplastic limbic encephalitis, and acquired autoimmunity played a major role in the pathogenesis of this case. (Internal Medicine 42: 428-432, 2003) 
Introduction
Amongpatients with encephalitis or encephalopathy of unknownetiology, there exist those who predominantly show cognitive decline with a sub-acute to chronic clinical course and who show an excellent response to steroid without obvious autoimmune disorders or steroid-dependent endocrinopathy. Consideration of the possibility of various types of encephalitis/encepalopathy as well as steroiddependent cognitive impairment is easier when these conditions occur in a younger population than in older patients. This is because cognitive impairment in elderly patients might be diagnosed as being merely senile or presenile dementia. Actually, there have been several reports of senile or pre-senile dementia that has been successfully treated with steroids, i.e. so called steroid-responsive dementia (1) or steroid-sensitive dementia (2) .
Weencountered such a case with cognitive impairment, one whoresponded excellently to both intravenous and oral steroid administrations, and whofurthermore showedlimbic abnormalities on MRLCerebrospinal fluid (CSF) analyses revealed the presence of autoantibodies that selectively recognized central nervous system (CNS) components, especially astrocytes. Weconsidered that the patient had limbic encephalitis. There was, however, no evidence of any malignant neoplasm. Furthermore, antoantibodies found in this case differed from the ones found in the patients with paraneoplastic limbic encephalitis (PLE) (3). This case should be meaningful regarding encephalitis associated with limbic abnormalities, steroid sensitivity and autoantibodies in limbic encephalitis. Wetherefore report the details of this case, as well as a literature review of similar cases.
Case Report
A 71-year-old man experienced low-grade fever and fine tremors in both hands at the end of December 1996. One weekafter the onset, five or six red spotty eruptions were noticed which looked as if he had been stuck by a needle in the left femoral cutis. The eruptions disappeared after several days without any treatment. Five days later, he became aware of an itching pain in the bilateral femoral regions, and he complained that this was unbearable even when his own clothes rubbed against the femoral cutis. The next day, the same pain spread to the left temporal skin of his scalp. On January 12, he was admitted to another hospital with a 38°C fever, a shaking chill and loss of appetite. The patient had lost 7 kg in weight since the onset. Several days after admission, he could not remember how, why and with whomhe had been admitted to the hospital. The unbearable pain in the head and femoral cutis disappeared after use of a non-steroidal anti-inflammatory agent. He was discharged from the hospital on January 26, although a minor fever still eccho, coxsackie, mumps, measles, rubella, varicella zoster, herpes simplex, Epstein-Barr, Japanese encephalitis, and cytomegalo virus) were all within normal limits. Myelin basic protein was 4.9 ng/ml (normal<4.0 ng/ml). Antineuronal-cell antibodies seen in paraneoplastic syndrome, including anti-Hu antibodies were absent in the CSF. Cranial MRI revealed bilateral limbic system abnormalities, with low signal intensity on Tl-weighted image (T1WI) and high signal intensity on T2WI (Fig. 1A , B, C, and D). EEGabnormalities were improved by valproate sodium therapy; however, amnesic symptoms showed no obvious change. After confirming no beneficial effect of the intravenous administration of aciclovir (1,000 mg daily for 10 days), a course of methylprednisolone (500 mg/day for 3 days) followed by oral prednisolone (30 mg/day) was started.
As a result of the methylprednisolone treatment, malaise disappeared and low grade fever was completely resolved. points on May 31 1998. The patient now visits our hospital once a month and shows no neurological deficits with a daily 7.5 mg intake of prednisolone and the patient and his family have no complaints. His wife says that previously he was very shy and reticent before the onset of the disease but that subsequently he has become a talkative and jolly person. We consider that the patient's mental alteration is a consequence of the disease rather than any adverse effect of steroid therapy. Wecould not rule out the possibility that this patient was suffering from PLE, because paraneoplastic symptoms sometimesprecede the appearance of any evident neoplasm (3) . Using immunoblotting we subsequently analyzed the CSFderived from the patient to confirm whether or not there were antibodies that recognized the CNScomponents as in a previous report (4) (Fig. 2A) . As a consequence we found antibodies that mainly react with humanwhite matter extract at 38 to 42 kDa fractions. There were several indistinct bands in the white matter at 38 to 50 kDa and in the gray matter at 42 kDa. These antibodies did not react with non-CNS tissues orcells.
Immunohistological procedures (4) involving staining according to the avidin-biotin peroxydase complex (ABC) method showedthat the autoantibodies reacted with a cytoplasm of astrocytes in an acetone-fixed specimen derived from frozen rat cerebrum (subpial, cortico-medullary junction and other whole cerebral regions) (Fig. 2B) . These results seemedto correspond to the white matter abnormalities in the MRIexamination. pathy (7) with limbic abnormality and with the absence of cancer (non-paraneoplastic limbic encephalitis or encephalopathy: non-PLE). Just as with PLE, non-PLE discloses peripheral nerve involvement with high frequency (6, 7). The etiological candidate of non-PLE is considered to be autoimmunity or an infectious agent. Due mainly to the rarity of the cases, the application of steroids for these conditions is not mentioned. As rare cases whose affected lesions wererestricted in the limbic systems, Kohler et al (8) reported on two cases of limbic encephalitis without malignancy. Onepatient developed progressive dementia and died 8 months after the onset. The other patient showed amnesic syndrome that was stabilized with high-dose dexamethasone treatment over 12 months. These two also had epileptic seizures and showed signs of mild lymphocytic pleocytosis in the CSF. The authors concluded that limbic encephalitis is caused not only by the remote effect of a neoplasm but also by immunological mechanisms, and that the use of steroids may be beneficial in this condition. Recently, Mori et al (9) reported a 21-year-old womanwho subacutely developed memory loss subsequent to gastroenteritis as non-PLE. Combined immunosuppressive treatment with plasmapheresis and immunoglobulin improved the patient's clinical symptoms.
Western blot and immunohistochemical analyses of CSF obtained from such patients reveal the presence of antibodies that react to between 38 and 50 kDa astrocyte components. In Table 1 , we summarized the representative autoantibodies related to PLE. Antibodies found in our case differ from any antibodies listed in the Table 1 with regard to antigenexpressing cell types or the molecular weight of the antigens. Regarding the presence of the anti-white matter antibodies, Kaneko et al (10) reported a demented patient who had serum autoantibody that reacted to a 48 kDa nuclear protein in humanastrocytes and neurons. The patient exhibited white matter abnormalities in MRI, a finding that resembles the present case. However, the symptoms of the patient did not respond to oral steroid therapy. On the other hand, in three patients with ordinary PLE in the absence of anti-Hu antibodies, Honnorat et al (1 1) identified the presence of antibodies that recognized a cytoplasmic antigen in a subpopulation of glial cells in the white matter, especially oligodendrocytes. Whether or not the anti-white matter antibodies play an essential role in the pathogenesis of these cases, or are merely an immunological reaction following the destruction of the white matter components, is unknown. Howeverthe glial cells, as well as neurons, seem to be potential targets of the immuno-mediated attacks.
In a literature' review with regard to steroid sensitive encephalitis/encephalopathy without malignant neoplasm, and autoantibodies that selectively recognize CNS compo- nents and relate to cognitive impairment, some of the cases reviewed seem to be related to para-or post-infectious conditions, while others seem to be related to autoimmunity. In particular, in the present case, the episode occurred in the course of an acute exanthematous disorder. Wedo not recommendpatients with cognitive impairment and putatively with immunological abnormalities to undergo a course of empirical corticosteroids, or other immunosuppressive therapies. However, it is important to note that there are a few patients whoexhibit an excellent response to steroids, and who, therefore, are potentially treatable.
